Hims and Hers Hims and Hers has become one of the most recognizable names in telehealth weight management
However, studies have also found that GLP-1 therapies can result in the loss of muscle mass
NICE Technology Appraisal (TA875) recommends semaglutide (Wegovy) only for adults with at least one weight-related comorbidity and a BMI 35 kg/m (or 32.5 kg/m for people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean backgrounds)
The Trajectory of Enforcement: From September to Now The initial salvo in September 2025 was unprecedented in scale
The study also observed additional health benefits associated with GLP-1 use, such as reductions in waist circumference and systolic blood pressure, and improvements in various metabolic parameters like blood glucose and cholesterol levels
A clinician can review whether trial participation or another therapy fits your medical history